Canada · Delayed Price · Currency is CAD Microbix Biosystems Company Description
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
| Country | Canada |
| Founded | 1988 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 70 |
| CEO | Cameron Groome |
Contact Details
Address: 265 Watline Avenue Mississauga, ON L4Z 1P3 Canada | |
| Phone | 905 361 8910 |
| Website | microbix.com |
Stock Details
| Ticker Symbol | MBX |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| ISIN Number | CA59501P1045 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Cameron L. Groome | President, Chief Executive Officer and Director |
| James S. Currie | Chief Financial Officer |
| Dr. Kenneth Hughes Ph.D. | Chief Operating Officer |
| Phillip Casselli | Senior Vice President of Sales and Business Development |
| Dr. Mark Luscher Ph.D. | Senior Vice President of Scientific Affairs |
| Christopher B. Lobb | Compliance Officer, General Counsel and Secretary |